- CMRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $31.2 million.
- CMRX has traded 2,379 shares today.
- CMRX is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CMRX with the Ticky from Trade-Ideas. See the FREE profile for CMRX NOW at Trade-Ideas More details on CMRX: Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral antivirals to address unmet medical needs in the United States. Currently there are 9 analysts that rate Chimerix a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Chimerix has been 399,500 shares per day over the past 30 days. Chimerix has a market cap of $1.8 billion and is part of the health care sector and drugs industry. The stock has a beta of -0.15 and a short float of 8.6% with 3.96 days to cover. Shares are up 5.4% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.